|
Selected Factors Associated with Metabolic Syndrome in Persons Living with HIV/AIDS Receiving Antiretroviral Therapy |
|---|---|
| รหัสดีโอไอ | |
| Creator | 1. Panthip Khaokaew 2. Wantana Maneesriwongul 3. Panwadee Putwatana |
| Title | Selected Factors Associated with Metabolic Syndrome in Persons Living with HIV/AIDS Receiving Antiretroviral Therapy |
| Publisher | Text and Journal Publication |
| Publication Year | 2561 |
| Journal Title | Vajira Medical Journal |
| Journal Vol. | 62 |
| Journal No. | 5 |
| Keyword | Factors, metabolic syndrome, antiretroviral therapy, HIV/AIDS |
| URL Website | https://tci-thaijo.org/index.php/VMED |
| Website title | Vajira Medical Journal (วชิรเวชสาร) |
| ISSN | 0125-1252 |
| Abstract | Abstract Objective: The aims of this descriptive study were to determine prevalence of metabolic syndrome, and explore factors associated with metabolic syndrome in persons living with HIV/AIDS (PLHA) receiving antiretroviral therapy (ART) . Methods: A sample of 424 PLHA receiving ART at SENA Hospital was recruited. Data collection tools composed of personal data and health history, medical records, and ART records. The statistics for analyzing data included descriptive statistics frequency, percentage, mean, standard deviation, range, and odds ratio statistics to investigated factors associated with metabolic syndrome. Metabolic syndrome was defined by the National Cholesterol Education Program - Adult Treatment Panel III (NCEP-ATP III) . Results: This study revealed that prevalence of metabolic syndrome was 28.10%. Significant risk factors associated with metabolic syndrome were female gender (OR=1.6; 95%CI=1.06-2.51; p=0.031), age ? 45 years (OR=1.6; 95 % CI =1.10-2.60; p =0.022), body mass Index ? 25 kg/m2 (OR=4.5; 95%CI=2.069-4.56; p= .000), CD4 > 400 cell/mm3 (OR=1.8; 95%CI=1.22-2.90; p=0.005), ART regimen with Didanosine, Stavudine, Efavirenzor Protease inhibitors (OR=1.9; 95%CI =1.15-3.39; p=0.018), and ART duration ?12 months (OR=2.7; 95%CI=1.13-6.70; p =0.031) . Conclusion: The results of this study showed that prevalence of metabolic Syndrome in PLHA receiving ART is relatively high compared to previous studies. Therefore, health providers should encourage PLHA receiving ART to have appropriate health promoting behaviors to prevent the metabolic syndrome which can increase risk for cardiovascular disease. |
